Compounds > tadalafil
Page last updated: 2024-09-02

tadalafil and Day Blindness

tadalafil has been researched along with Day Blindness in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aliferis, K; Farpour, B; Matter, MA; Petropoulos, IK; Safran, AB1
Oguz, H; Verit, A1
Wooltorton, E1

Other Studies

5 other study(ies) available for tadalafil and Day Blindness

ArticleYear
Can Viagra really cause hearing and vision loss? If so, is this a reason to avoid using it?
    Mayo Clinic health letter (English ed.), 2008, Volume: 26, Issue:7

    Topics: Carbolines; Hearing Loss; Humans; Imidazoles; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Time Factors; Triazines; Vardenafil Dihydrochloride; Vision Disorders

2008
Tadalafil: visual and auditory disorders. Inform patients of these risks.
    Prescrire international, 2011, Volume: 20, Issue:121

    Topics: Carbolines; Hearing Disorders; Humans; Phosphodiesterase 5 Inhibitors; Risk; Tadalafil; Vision Disorders

2011
Should central serous chorioretinopathy be added to the list of ocular side effects of phosphodiesterase 5 inhibitors?
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2012, Volume: 227, Issue:2

    Topics: Aged; Carbolines; Central Serous Chorioretinopathy; Erectile Dysfunction; Fluorescein Angiography; Humans; Imidazoles; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Sulfones; Tadalafil; Tomography, Optical Coherence; Triazines; Vardenafil Dihydrochloride; Vision Disorders

2012
Ophthalmic aspects of erectile dysfunction drugs.
    American journal of ophthalmology, 2006, Volume: 141, Issue:3

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adverse Drug Reaction Reporting Systems; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Optic Neuropathy, Ischemic; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vision Disorders

2006
Visual loss with erectile dysfunction medications.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2006, Aug-15, Volume: 175, Issue:4

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Atherosclerosis; Carbolines; Erectile Dysfunction; Humans; Imidazoles; Male; Optic Neuropathy, Ischemic; Phosphodiesterase Inhibitors; Piperazines; Purines; Risk Factors; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vision Disorders

2006